|
期刊名称：JOURNAL OF ORTHOPAEDIC TRAUMA
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Lippincott Williams& Wilkins is pleased to announce the impending release of PROMpT, a new online manuscript submission, review, and tracking system for this website. PROMpT facilitates various author and reviewer-related processes. Using PROMpT, authors can submit new manuscripts for review, deliver requested manuscript revisions, and track the status of their submissions. Reviewers can use PROMpT to access submission review assignments, return manuscript comments and acceptance decisions, and participate in other review processes in a few easy steps. We invite contributors and reviewers to begin using the PROMpT interface when it is released in the coming days. Please continue to visit the site for additional information and a link to the dedicated JOT PROMpT website
Journal of Orthopaedic Trauma is devoted exclusively to the diagnosis and management of hard and soft tissue trauma, including injuries to bone, muscle, ligament, and tendons, as well as spinal cord injuries. Under the guidance of a distinguished international board of editors, the journal provides the most current information on diagnostic techniques, new and improved surgical instruments and procedures, surgical implants and prosthetic devices, bioplastics and biometals; and physical therapy and rehabilitation.
|
|
Instructions to Authors
Instructions for Authors
Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium.
In addition to full-length articles, the Journal will consider for publication case reports, brief communications on emerging technologies, and descriptions of new techniques (surgical, clinical, and experimental). Letters to the Editor are welcomed and will be sent to the manuscript authors for their response. Subsequent publication of this dialogue is solely at the discretion of the Editor-in-Chief.
The Journal will also periodically publish non-peer-reviewed invited state-of-the-art reviews, historical perspectives, biographical sketches, and Point of View commentary. Interested contributors should contact the Editorial office for further direction.
All manuscript submissions and correspondence should be sent to:
Roy Sanders, M.D.
Editor-in-Chief
Journal of Orthopaedic Trauma
4 Columbia Drive
Suite #710
Tampa, Florida 33606
Telephone: (813) 253-2068
Facsimile: (813) 254-4113
E-mail: JOTEditor@aol.com.
Length of Follow-up. The Journal will accept clinical studies that have strictly observed a sufficient length of time for follow-up. For soft tissue injuries and nonarticular fractures, the recommended minimum follow-up period is one (1) year. For articular injuries, nonunions, and deformities, the recommended minimum follow-up period is two (2) years. Studies based solely on a review of chart material for outcome data will not be accepted.
Authorship Criteria and Responsibility. One author should be designated as the corresponding author and provide a complete address, telephone and facsimile numbers, and e-mail address. Manuscripts should have no more than six (6) authors: a greater number requires justification. If authorship is attributed to a group, either solely or in addition to one or more individual authors, all members of the group must meet full criteria and requirements for authorship. One or more authors may take responsibility "for" a group, in which case the other group members are not authors but may be listed in an acknowledgment. A copy of the manuscript authorship responsibility, assignment of copyright, device status and financial disclosure statements, and acknowledgments form must be signed by each author and submitted.
Device Status. Following the acceptance of a manuscript, a device status statement must be filled out by the authors and will be published with the article:
- The manuscript submitted does not contain information about medical devices.
- The legal/regulatory status of the device(s), that is/are the subject of this manuscript is not applicable in my country.
- The device(s) that is/are the subject of this manuscript have been cleared through the Premarket Notification (510(k)) process/approved through a Premarket Approval application for the surgical indications studied.
- The device(s) that is/are the subject of this manuscript has/have been cleared through the Premarket Notification (510(k)) process/approved through a Premarket Approval application for [state the specific indication on a separate piece of paper and attach], but not for the surgical indications that were reported
- The device(s) that is/are the subject in this manuscript is/are being evaluated as part of an ongoing FDA-approved investigational protocol (IDE) for [state the specific indication on a separate page and attach].
- The device(s) that is/are the subject of this manuscript is/are exempt from FDA regulations because [state the specific indication on a separate page and attach].
- The device(s) that is/are the subject of this manuscript is/are not FDA-approved and is/are not commercially available in the United States.
- The device(s) that is/are the subject of this manuscript is/are not intended for human use.
- The legal/regulatory status of the device(s) that is/are subject of this manuscript is/are not known by the author(s).
- The author(s) of this manuscript has/have chosen not to furnish information to the Journal of Orthopaedic Trauma and its readers regarding the legal/regulatory status of the device(s) that is/are the subject of this manuscript.
- The device(s) that is/are the subject of this manuscript is/are FDA-approved.
Preparation of Manuscripts. Authors should note that failure to adhere to the following instructions will result in the return of their manuscript for technical revision before undergoing peer review.
General Format. Manuscripts are sent to reviewers blinded; therefore do not include author(s) name(s) or institution(s) on text pages or figures. The authors names and institutions should appear only on the title page and submission letter. The original manuscript and three (3) copies complete with illustrations must be submitted. Use only one side of standard white bond paper of the size 8.5 x 11 inches (216 x 279 mm).
Each manuscript must contain the following elements: Title, Structured Abstract, Key Words, Text, References, Tables, and Legends. Each element must appear on a new page. Double space throughout entire manuscript. Do not indent start of each paragraph. Margins are to be one (1) inch (25 mm) on all borders. Font size must be 12 point. Line numbering (continuous) must be shown on left margin. Write out figures under 100 except percentages, degrees, or figures expressed in decimals. All measurements should be given in System Internationale (SI) metric units, given in parentheses throughout text. Authors must type out all mathematical and chemical symbols, equations, and formulas and identify in the margin all unusual symbols the first time they are used. Use generic names when referring to drugs. List company and its geographic location for commercial products (e.g., Howmedica, Rutherford, NJ, U.S.A.). Avoid slang and jargon (e.g., interlocked intramedullary nail, not doublelocked rod). Although other fracture classifications may be used, please classify all fractures according to The Orthopaedic Trauma Association Classification of Fractures (Supplement, July 1996).
Each page must have an abbreviated version of the manuscript title (running head) of no more than forty (40) characters (including letters and spacing). Do not include authors. The running head should appear at the top left-hand corner of each page. Consecutive numbering must appear on the top right-hand corner of each page, beginning with the second (blinded) title page.
Title Page. Two title pages are required. The first should include the title of the article, a short running head, author(s) name(s) and degree(s), institutional affiliation(s), financial disclaimers, funding sources, device status statement, and any acknowledgments. In addition, the name, address, and telephone and facsimile numbers of both the corresponding and reprint request authors should be noted. The second title page should list only the title of the manuscript.
Structured Abstract and Key Words. The page following the blinded title page must contain a structured abstract of no more than 250 words. This is required for all reports of original data from either clinical or basic science investigations as well as for review articles (including meta-analyses). The structured abstract for clinical and basic science studies should contain each of the following sections in order:
Objectives (the exact question addressed by the article), Design (randomized, prospective, etc.), Setting (the location and level of clinical care), Patients/Participants (the manner of selection and number of patients who enter and complete the study), Intervention (the exact treatment used), Main Outcome Measurements (the primary study measure as planned before data collection began), Results, and Conclusions.
For reviews and meta-analysis, the structured abstract should contain: Objectives, Data Sources (specify database, search methodology, languages covered, and time frame), Study Selection (criteria used to select articles for detailed review), Data Extraction (means of assessing quality, validity, and comparability of extracted data), Data Synthesis (statistical techniques used for analysis), and Conclusions. For further information regarding structured abstracts, please refer to Haynes et al., More informative abstracts revisited. Ann Int Med 113:69---76, 1990.
Provide up to five key words that will assist indexers in cross-referencing your article.
Text. The text is to be divided into four sections with the following headings, each starting on a new page: Introduction, Materials and Methods, Results, and Discussion. The introduction should be limited to two to three paragraphs of pertinent information. The discussion should not be an exhaustive review of the literature; it should be succinct and limited to conclusions that can be reached based on your results. Please note that the text of manuscripts is restricted to fifteen (15) pages (excluding references). Longer manuscripts will not be considered.
References. References should be listed alphabetically, numbered consecutively, double-spaced, and placed at the end of the text in this order: author(s) last name(s), initial(s), title of article, journal name (abbreviation according to Index Medicus), year of publication, volume number, and first and last page according to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Provide all author names where there are seven or fewer co-authors. In the event that there are more than seven co-authors, list only the first three and use et al. "Personal communications" and "unpublished data" should be indicated within the text but excluded from the reference list (permission of those quoted will need to be furnished). Each reference must be cited in the text. Please refer to references in this copy of the Journal and follow style exactly.
Figures. A maximum of eight (8) figures may accompany the manuscript. Do not list author(s) name(s), or institution(s), on back of figures. Rather, please indicate figure number, orientation (top), and running head. Glossy, unmounted, 5 x 7 inches (127x 173 mm) black-and-white photographic prints are required. Submit four (4) collated sets. Supply an accompanying legend for each figure typed double spaced on a sheet of paper separate from the actual figure (placed after the references). For photomicrographs, indicate stain and magnification, limiting field to pertinent pathology only. Color illustrations are welcome but processing costs will be paid by authors via a contractual agreement with the Publisher.
Digital figures. Electronic art should be submitted as either a TIFF (tagged image file format) or an EPS (encapsulated postscript) file. Line art must have a resolution of at least 1200 dpi (dots per inch), and electronic photographs_radiographs, CT scans, and so on_and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be saved and submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Files can be submitted on a 3_-inch high-density disk, a CD-ROM, or an Iomega Zip disk. Please note that artwork generated from office suite programs such as Power Point, Corel Draw, and MS Word and artwork downloaded from the Internet (JPEG or GIFF files) cannot be used. Tables. Each table, along with its title or caption, should be on a separate sheet of paper. Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
Permissions. Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Editorial Review Process ?Manuscript Review. All submissions are initially reviewed by the editorial staff to ensure that the manuscript complies with the above criteria. Manuscripts that meet these requirements are then sent to two (2) expert consultants for peer review. Peer reviewer identities are kept confidential. Differing opinions will require a delay in the decision, because a third reviewer's opinion will be obtained. The final decision for acceptance/rejection rests with the Editorial Board. Authors will be notified of the outcome as soon as possible. Rejected manuscripts (including illustrations) will not be returned to the authors.
If a manuscript is accepted, authors will receive a detailed blinded explanation from the Editors regarding changes (if any) to be made to the manuscript, before final acceptance. When submitting the revision, the author(s) must respond and indicate by page number, paragraph, and line number where changes have been made, addressing all the points of the reviewers. Failure to comply may result in a delay in publication. Failure to respond to requests for revision in excess of twelve (12) months will be perceived by the Editors as a lack of interest in publishing the study. The authors will be notified that the manuscript will be discarded, and if resubmitted will be treated as a new manuscript.
Manuscript on Disk. The Journal of Orthopaedic Trauma prefers authors to submit manuscripts on disk. Lippincott Williams & Wilkins will accept submission of electronic versions of manuscripts in conjunction with the traditional paper version. The preferred method of submission is a 3.5 inch disk in an MS-DOS/Windows compatible format. Files in Macintosh-compatible format will also be accepted. The preferred word processing formats are WordPerfect or Word. Other formats will be accepted but the vagarities of conversion may produce errors. Do not submit ASCII text files. Do not use automatic numbering for references (i.e., "endnotes" in WordPerfect). Each submitted disk must be clearly labeled with the name of the author, item title, journal title, word processing program and version, and file name used. This disk should contain only one file: the final version of the submitted manuscript. If the manuscript is accepted, the Editor will contact the corresponding author with formatting instructions so that the disk may be used for final typesetting of the article.
Editorial Board
The Journal of Orthopaedic Trauma is devoted exclusively to the diagnosis and management of hard and soft tissue trauma, including injuries to bone, muscle, ligament, and tendons, as well as spinal cord injuries. Under the guidance of a distinguished international board of editors, the journal provides the most current information on diagnostic techniques, new and improved surgical instruments and procedures, surgical implants and prosthetic devices, bioplastics and biometals; and physical therapy and rehabilitation.
| |
|
| |
Business Correspondence
Publisher
Marcia Serepy
E-mail: mserepy@lww.com
Advertising Sales Representative
Renèe Artuso
E-mail: rartuso21@cs.com
Business Offices
Lippincott Williams & Wilkins
530 Walnut Street
Philadelphia, PA 19016
Phone: 215-521-8300
http://www.lww.com
|
|
Editorial Correspondence
Editor-in-Chief
Roy Sanders, M.D.
Journal of Orthopaedic Trauma
4 Columbia Drive
Suite #710
Tampa, Florida 33606
Phone: 813-253-2068
Fax: 813-254-4113
E-mail: joteditor@aol.com
|
|
|
|
|
In Association with: